How long does it take to lose weight on semaglutide?

What happens in the first few weeks — and why the scales move slowly at first?

The first pen of Wegovy delivers 0.25mg weekly. That dose exists purely to let your body adjust; nausea and other gastrointestinal effects are most likely during this settling-in phase, and the appetite-suppressing effect is mild. Most people notice some reduction in hunger fairly quickly, but the scales rarely shift dramatically in weeks one to four. A loss of 1–2kg is common. Some people see a little more, some see less.

From week five, the dose moves to 0.5mg, then 1.0mg, 1.7mg, and finally 2.4mg, each step roughly four weeks apart. Weight loss tends to accelerate meaningfully around the 1.0mg and 1.7mg stages, as appetite suppression becomes more consistent and gastric emptying slows enough to change eating behaviour in a durable way. The pace of loss in those middle months is when most patients feel the treatment is working.

One practical note from patients: keeping the pen in the fridge door alongside everyday items makes the weekly injection feel like part of a routine rather than a clinical event, which tends to support consistency.

How much weight can you realistically expect to lose, and over what timeframe?

The STEP 1 trial is the most cited source for a reason. Over 68 weeks, adults without diabetes using semaglutide 2.4mg alongside lifestyle support lost an average of around 15% of their starting weight — roughly 15kg for someone starting at 100kg. That is an average: some participants lost considerably more, others less. The trial was conducted in a controlled setting with structured lifestyle support, so real-world results vary.

A more recent development: the MHRA approved a higher 7.2mg dose of Wegovy in January 2026, with a dedicated single-dose pen confirmed in April 2026. Trial data for 7.2mg showed average losses of around 20.7% over 72 weeks, narrowing the gap with tirzepatide at its highest dose. That dose is titrated to over time, not started at; semaglutide how long it takes to reach the top of the schedule depends on how well each step is tolerated.

NICE's recommendation for semaglutide (Wegovy) under appraisal TA875 includes a review point: if less than 5% of starting weight is lost after six months at the maintenance dose, the prescriber and patient should reconsider whether continuing is the right choice. That review process is built into good clinical practice, not a sign of failure.

Does the rate of loss slow down, and what affects the overall timeline?

Yes. Most people experience a plateau at some point, typically after six to twelve months of treatment. The body adapts, basal metabolic rate adjusts, and the rate of loss flattens even while weight continues to trend downward. This is normal physiology, not a sign that semaglutide has stopped working.

Several factors shape how quickly an individual loses weight. Starting BMI plays a role, those with a higher starting weight often lose more in absolute terms but may lose a similar proportion. Physical activity levels matter: the medicine reduces appetite but does not change the body's response to strength and cardiovascular exercise, which preserves muscle mass and supports the calorie deficit. Diet quality affects how much of the appetite reduction translates into a sustainable lower intake.

There is also the question of how consistently the injection is taken. Missing doses, particularly in the early stages, interrupts the steady-state effect. Questions about your personal pace of progress are best raised directly with a prescriber who can look at your full clinical picture. You can also explore general FAQs on the topic.

What happens to the weight if semaglutide is stopped?

This is the question many people find uncomfortable but important to answer honestly. Clinical evidence shows that a substantial proportion of weight lost during semaglutide treatment returns within a year of stopping, particularly if no lasting changes to diet and activity have taken hold. Weight regain is a biological response driven by the re-emergence of appetite-regulating hormones, not a personal failure.

NICE's recommendation for semaglutide on the NHS specifies a maximum treatment duration of two years within a specialist weight management service. Private prescribing follows clinical judgement rather than a fixed cut-off, though the same principle applies: long-term use should be clinically reviewed. Understanding how Wegovy works over time helps frame what stopping means for you individually.

For context on what treatment involves beyond the medicine itself, the weight loss overview page sets out the broader picture. If cost is a factor in planning, Wegovy pricing information explains what private treatment typically includes. Speak to our prescribers if you want a clinical view on how long treatment might be appropriate for your situation.